바이오인

 

 

In collaboration with Agency for Science, Technology and Research (A*STAR) and held in conjunction with the International Society of Differentiation Organizers: Sir David P. Lane, Hans C. Clevers, Arnold J. Levine and Xin Lu

Recent studies on the affect of polymorphisms in human tumor suppressor pathways on cancer incidence and longevity have confirmed long held views of the link between the key processes that control human aging and cancer incidence. One interpretation of these
findings is that the stem cell is the key target for carcinogenesis.
Further, the thresholds that regulate stem cell death in response to damage make the bargain between too-resilient stem cells which result in long life but increased cancer risk, and too-sensitive stem cells which ablate the occurrence of cancer but can shorten life span through stem cell exhaustion. Dramatic progress in the understanding of signaling pathways and points of intervention which will be debated in this meeting offer the enticing prospect of
regulating these pathways to extend healthy lifespan and reduce cancer incidence in the human population.